Hydration, Indomethacin to Prevent Pancreatitis After ERCP
Investigators performed a meta-analysis to determine which clinical strategy is most effective for the prevention of PEP in patients with ERCP.
Investigators performed a meta-analysis to determine which clinical strategy is most effective for the prevention of PEP in patients with ERCP.
Researchers investigated clinical outcomes in patients with acute pancreatitis and concomitant SARS- CoV-2 infections.
Pancreatic exocrine function has long been suspected of playing a role in type 1 diabetes.
Acute pancreatitis may be a gastrointestinal manifestation of COVID-19.
Based on a case-crossover analysis, there was an increased risk for acute pancreatitis associated with ongoing methimazole/carbimazole or propylthiouracil treatment.
Use of dipeptidyl peptidase-4 inhibitors is associated with an increased risk for pancreatitis and pancreatic cancer in patients with newly diagnosed type 2 diabetes.
Liraglutide does not increase the risk for acute pancreatitis in patients with type 2 diabetes who are also at high risk for cardiovascular events.